Live updates: FDA panel reviewing Johnson & Johnso
Post# of 4861
Latest: Johnson & Johnson scientists present data to back their one-shot vaccine
A Food and Drug Administration advisory committee is meeting Friday to review the safety and efficacy of Johnson & Johnson’s coronavirus vaccine, setting the stage for FDA authorization as early as this weekend.
If cleared, the shot would be the United States’ third vaccine against the pathogen, but the only one that provides protection with a single dose. Experts say it could expedite efforts to inoculate the population as virus variants spread.
https://www.washingtonpost.com/nation/2021/02...pdates-us/
TOODLES